Home » NEUTEC COMPLETES RECRUITMENT FOR MRSA DRUG TRIAL
NEUTEC COMPLETES RECRUITMENT FOR MRSA DRUG TRIAL
June 16, 2006
NeuTec Pharma has completed recruiting patients for the final trials of its experimental drug Aurograb, which targets the hospital "superbug" MRSA.
The Phase III study has recruited 161 adults, and results are expected at the end of the year.
KEYWORDS Drug Pipeline Alert